Literature DB >> 10760821

Non-random trisomies of chromosomes 5, 8 and 12 in the prolactinoma sub-type of pituitary adenomas: conventional cytogenetics and interphase FISH study.

P Finelli1, D Giardino, N Rizzi, S Buiatiotis, T Virduci, A Franzin, M Losa, L Larizza.   

Abstract

Specimens from 53 pituitary adenomas (PAs), including 17 NFPA, 16 PRL-, 9 ACTH-, 9 GH- and 2 TSH-secreting tumors, underwent cytogenetic analysis by the direct and short-term culture methods. Only 8 tumors (15%) appeared to have an abnormal karyotype. To increase the resolution of cytogenetic analysis, direct preparations from 31 PAs were investigated by interphase FISH with probes specific for chromosomes 5, 8, 12 and X, for which gain in pituitary tumors has been reported. Of these 31 PAs, 17 (54.8%) had an abnormal dosage of one or more of the 4 chromosomes tested. Separate or combined trisomies of chromosomes 5, 8 and 12 were found in 10/10 prolactinomas and in 4/9 NFPA, whereas the combined loss of chromosomes 5 and 8 was observed in 1/6 ACTH- and 1/6 GH-secreting PAs. Present and earlier data on 23 PAs showed that tumors with the highest frequency of abnormal karyotypes revealed by cytogenetics and/or interphase FISH were PRL (78%), followed by NFPA (26%) and GH (18%). Recurrent structural rearrangements affecting chromosomes 1, 3 and 12 were also identified in prolactinomas, which therefore appear to be the only pituitary adenoma sub-type with a defined trend of tumor-specific chromosomal changes. Cytogenetic and FISH analyses of different pituitary tumor sub-types indicate that they may harbour genetically distinct lesions. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 10760821     DOI: 10.1002/(sici)1097-0215(20000501)86:3<344::aid-ijc7>3.0.co;2-8

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

1.  Examination of the relationship between chromosome abnormality in pituitary adenomas and tumor invasiveness by normal karyotype analysis and interphase fluorescence staining.

Authors:  Heng Gao; Qiping Wang; Sirong Wu; Guozhen Hui
Journal:  Med Oncol       Date:  2012-07-07       Impact factor: 3.064

2.  Amplified HMGA2 promotes cell growth by regulating Akt pathway in AML.

Authors:  Li Tan; Xiaoping Wei; Lixia Zheng; Jincai Zeng; Haibo Liu; Shaojiang Yang; Huo Tan
Journal:  J Cancer Res Clin Oncol       Date:  2015-08-30       Impact factor: 4.553

3.  Fusion of platelet-derived growth factor receptor β to CEV14 gene in chronic myelomonocytic leukemia: A case report and review of the literature.

Authors:  Sheng-Lan Gong; Meng-Qiao Guo; Gu-Sheng Tang; Chun-Ling Zhang; Hui-Ying Qiu; Xiao-Xia Hu; Jian-Min Yang
Journal:  Oncol Lett       Date:  2015-11-18       Impact factor: 2.967

Review 4.  Genesis of pituitary adenomas: state of the art.

Authors:  G Faglia; A Spada
Journal:  J Neurooncol       Date:  2001-09       Impact factor: 4.130

5.  Crooke's hyalinization in silent corticotroph adenoma: report of two cases.

Authors:  Federico Roncaroli; Marco Faustini-Fustini; Francesco Mauri; Sofia Asioli; Giorgio Frank
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

Review 6.  The molecular pathogenesis of pituitary adenomas: an update.

Authors:  Xiaobing Jiang; Xun Zhang
Journal:  Endocrinol Metab (Seoul)       Date:  2013-12

Review 7.  Genetic and Epigenetic Causes of Pituitary Adenomas.

Authors:  Mengqi Chang; Chengxian Yang; Xinjie Bao; Renzhi Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-26       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.